International Journal of Cancer Management

Published by: Kowsar

Association of Arg194Trp and Arg399Gln Polymorphisms of XRCC1 Gene and Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients

Mina Adampourezare 1 , Mohammad-Ali Hosseinpourefeizi 1 , * , Nasser Pouladi 2 , Ehsan Hosseinpourefeizi 3 and Parvin Azarfam 1
Authors Information
1 Department of Biology, Faculty of Natural Sciences, Tabriz University, Tabriz, IR Iran
2 Department of Cellular and Molecular Biology, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, IR Iran
3 Department of Biology, Faculty of Natural Sciences, Department of Genetics, Islamic Azad University, Ahar Branch, Tabriz, IR Iran
Article information
  • International Journal of Cancer Management: July 2017, 10 (7); e5790
  • Published Online: July 31, 2017
  • Article Type: Research Article
  • Received: February 24, 2016
  • Revised: October 1, 2016
  • Accepted: July 11, 2017
  • DOI: 10.5812/ijcm.5790

To Cite: Adampourezare M, Hosseinpourefeizi M, Pouladi N, Hosseinpourefeizi E, Azarfam P. Association of Arg194Trp and Arg399Gln Polymorphisms of XRCC1 Gene and Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients, Int J Cancer Manag. 2017 ; 10(7):e5790. doi: 10.5812/ijcm.5790.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol. 2005; 162(10): 925-42[DOI][PubMed]
  • 2. Pramanik S, Devi S, Chowdhary S, Surendran ST, Krishnamurthi K, Chakrabarti T. DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India. Chemosphere. 2011; 82(7): 941-6[DOI][PubMed]
  • 3. Caldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol. 1994; 14(1): 68-76[PubMed]
  • 4. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 1996; 15(23): 6662-70[PubMed]
  • 5. Vidal AE, Boiteux S, Hickson ID, Radicella JP. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001; 20(22): 6530-9[DOI][PubMed]
  • 6. Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998; 58(4): 604-8[PubMed]
  • 7. Przybylowska-Sygut K, Stanczyk M, Kusinska R, Kordek R, Majsterek I. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer. 2013; 13(1): 61-8[DOI][PubMed]
  • 8. Ratnasinghe D, Yao SX, Tangrea JA, Qiao YL, Andersen MR, Barrett MJ, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2001; 10(2): 119-23[PubMed]
  • 9. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 1999; 20(11): 2125-9[PubMed]
  • 10. Al Mutairi FM, Alanazi M, Shalaby M, Alabdulkarim HA, Pathan AA, Parine NR. Association of XRCC1 gene polymorphisms with breast cancer susceptibility in Saudi patients. Asian Pac J Cancer Prev. 2013; 14(6): 3809-13[PubMed]
  • 11. Wein RO, Weber RS. Contemporary management of differentiated thyroid carcinoma. Otolaryngol Clin North Am. 2005; 38(1): 161-78[DOI][PubMed]
  • 12. How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ. 2007; 177(11): 1383-4[DOI][PubMed]
  • 13. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res. 1992; 131(1): 98-111[PubMed]
  • 14. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, et al. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989; 49(16): 4626-8[PubMed]
  • 15. Schantz SP, Hsu TC, Ainslie N, Moser RP. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA. 1989; 262(23): 3313-5[PubMed]
  • 16. Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009; 16(2): 491-503[DOI][PubMed]
  • 17. Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin JC, et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 2008; 14(18): 5919-24[DOI][PubMed]
  • 18. Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, Zeng X, et al. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med. 2009; 219(1): 43-51[PubMed]
  • 19. Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou W. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis. 2010; 25(3): 313-21[DOI][PubMed]
  • 20. Zhu QX, Bian JC, Shen Q, Jiang F, Tang HW, Zhang HW, et al. [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(8): 702-5[PubMed]
  • 21. Ho T, Li G, Lu J, Zhao C, Wei Q, Sturgis EM. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid. 2009; 19(2): 129-35[DOI][PubMed]
  • 22. Ryu RA, Tae K, Min HJ, Jeong JH, Cho SH, Lee SH, et al. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 2011; 26(8): 991-5[DOI][PubMed]
  • 23. Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000; 88(4): 601-6[PubMed]
  • 24. Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Z, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res. 2009; 171(1): 77-88[DOI][PubMed]
  • 25. Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, Cook DL, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res. 2001; 461(4): 273-8[PubMed]
  • 26. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003; 12(4): 359-65[PubMed]
  • 27. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2001; 10(2): 125-31[PubMed]
  • 28. Lee SG, Kim B, Choi J, Kim C, Lee I, Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett. 2002; 187(1-2): 53-60[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments